Health & Education
After taking over Lancet, Cerba remains on the offensive on the continent

After taking over Lancet, Cerba remains on the offensive on the continent

The leading biomedical company wants to accelerate the pace of its Covid-19 testing in Africa and continues to pursue its acquisition strategy.

Someone shares this article with you
            ▪ After taking over Lancet, Cerba remains on the offensive on the continent

▪ The leading biomedical company wants to accelerate the pace of its Covid-19 testing in Africa and continues to pursue its acquisition strategy.

http://www.jeuneafriquebusinessplus.com/en/804556/apres-la-prise-de-lancet-cerba-toujours-a-loffensive-sur-le-continent/

02/06/2020 at 16h33, by Jeune Afrique Business+

“We’ve been negatively impacted by supply chain tensions in recent weeks,” Stéphane Carré told Jeune Afrique Business+. He is Chief Executive Officer of Cerba Lancet Africa (CLA), a subsidiary of Cerba Healthcare, one the largest laboratory company’s in Europe, with €850m in revenue in 2018.

To read the article and discover your subscription benefits

You are connected to your Jeune Afrique account but your Jeune Afrique Business+ subscription does not allow you to consult the English version. To update your subscription, contact us by clicking here.

Any questions ? contact us

Please get in touch with the Jeune Afrique Business+ team if you require any further information.

Email us : abonnements@jeuneafriquebusinessplus.com

Add JAB+ to your home screen

1. Click on + at the bottom of your screen.

2. Click on + to add JAB+ on the home screen.

3. Enter the name of the shortcut and confirm.